Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated With Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-1862
Full Text
Open PDFAbstract
Available in full text
Date
December 13, 2013
Authors
Publisher
American Association for Cancer Research (AACR)